Dilsher Dhoot

Clinical trials

• Study to Evaluate Long-Term Safety of Intravitreal OTX-TKI (Axitinib Implant) in Participants With Neovascular Age-Related Macular Degeneration Who Successfully Completed 2-Year OTX-TKI-2023-AMD-301 or OTX-TKI-2023-AMD-303 Study

  Principal investigator · Recruiting · Phase 3

  Ocular Therapeutix, Inc.

  2026–2030
• Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Axitinib Implant) in Subjects With Neovascular Age- Related Macular Degeneration

  Principal investigator · Active not recruiting · Phase 3

  Ocular Therapeutix, Inc.

  2024–2027
• Variable Interval Versus Set Interval Aflibercept for DME

  Principal investigator · Completed · Phase 4

  California Retina Consultants

  2015–2018
• A Study in Adults With Geographic Atrophy

  Site PI · Recruiting · Phase 2

  Sitala Bio LTD

  2026–2029